| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/31/2008 | WO2008089593A1 Sustained release tamsulosin formulation and producing method |
| 07/31/2008 | WO2008089549A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | WO2008075984A3 Tablet formulation including macrocyclic lactone and levamisole anthelmintic agents |
| 07/31/2008 | WO2008075979A3 Tablet formulation |
| 07/31/2008 | WO2008071594A3 Polypeptides with the capacity to entrap drugs |
| 07/31/2008 | WO2008070345A3 Controlled release of a curing agent for the generation of microparticulate pharmaceuticals |
| 07/31/2008 | WO2008067234A3 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 07/31/2008 | WO2008062440A3 Programmable buoyant delivery technology |
| 07/31/2008 | WO2008062435A3 Stabilised dosage forms of amlodipine besylate |
| 07/31/2008 | WO2008061226A3 Sustained-release formulations of topiramate |
| 07/31/2008 | WO2008055626A8 Protein-containing substance with increased thermal stability |
| 07/31/2008 | WO2008041073A3 Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
| 07/31/2008 | WO2008039920A3 Temperature-sensitive nanoparticles for controlled drug delivery |
| 07/31/2008 | WO2008036801A3 Methods and systems of delivering medication via inhalation |
| 07/31/2008 | WO2008033031A3 Mri trackable drug delivery particles, uses and methods thereof |
| 07/31/2008 | WO2008032208A3 Extended release formulation of an antiepileptic agent |
| 07/31/2008 | WO2008031035A3 Engineering shape of polymeric micro-and nanoparticles |
| 07/31/2008 | WO2008030359A3 Topical compositions |
| 07/31/2008 | WO2008027263A3 Stimuli responsive polyester amide particles |
| 07/31/2008 | WO2008025033A3 Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia |
| 07/31/2008 | WO2008015221A3 Multilayer orally disintegrating tablet |
| 07/31/2008 | WO2008013929A3 Anti-migraine oral spray formulations and methods |
| 07/31/2008 | WO2008013558A3 Polypeptide films and methods |
| 07/31/2008 | WO2008011836A3 Ophthalmic solutions |
| 07/31/2008 | WO2008011087A3 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 07/31/2008 | WO2008009664A3 Treatment of pain |
| 07/31/2008 | WO2008006713A3 Improvements relating to anti-parasitic compositions |
| 07/31/2008 | WO2007146126A3 Insulin composition |
| 07/31/2008 | WO2007141050A3 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications |
| 07/31/2008 | WO2007127439A3 Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| 07/31/2008 | WO2007117605A3 Novel spill-resistant formulations comprising hydrocolloidal polymers |
| 07/31/2008 | WO2007109244A3 Novel nanoparticles for delivery of active agents |
| 07/31/2008 | WO2007075720A8 Topical mecamylamine formulations for ocular administration and uses thereof |
| 07/31/2008 | WO2006138571A3 Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance |
| 07/31/2008 | US20080183302 Prosthetic foot with tunable performance |
| 07/31/2008 | US20080183236 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves |
| 07/31/2008 | US20080183091 Cardiac event categorization system |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182959 Novel Temperature and pH Sensitive Copolymers |
| 07/31/2008 | US20080182933 Filler for Porous Film and Porous Film Containing the Same |
| 07/31/2008 | US20080182909 Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers |
| 07/31/2008 | US20080182828 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen and a progestogen equivalent to 90 mu g per day of norgestimate; hot flushes |
| 07/31/2008 | US20080181966 Modafinil pharmaceutical compositions |
| 07/31/2008 | US20080181965 polymeric particles made of copolymeric butyl acrylate, divinylbenzene, ethylstyrene, and poly(ethylene glycol) monomethyl ether methacrylate conjugated with peptide; protein; polysaccharide; nucleotide; oligonucleotide; nucleic acid; hapten; drug; biocompatible, resistant to adhesion of serum protein |
| 07/31/2008 | US20080181964 Microparticles |
| 07/31/2008 | US20080181963 Dermatological/cosmetic gels comprising at least one retinoid and benzoyl peroxide |
| 07/31/2008 | US20080181962 Formulation process method to produce spray dried products |
| 07/31/2008 | US20080181961 Amorphous oxcarbazepine and the production thereof |
| 07/31/2008 | US20080181960 Solid dispersion of completely amorphous carotenoids; polyvinylpyrrolidone, hydroxypropylcellulose hydroxypropylmethylcellulose solubility-enhancing polymers;spray dried powder increased bulk density; substantially free of lipids and oils |
| 07/31/2008 | US20080181959 Cinacalcet hydrochloride trade name SENSIPAR treat hyperparathyroidism in patients with chronic kidney disease on hemodialysis; povidone, poloxamer, hydroxypropyl methylcellulose; sucrose, mannitol, lactose; cinacalcet and carrier melt form a fusion product; hot melt extrusion system |
| 07/31/2008 | US20080181958 Nanoparticle fabrication methods, systems, and materials |
| 07/31/2008 | US20080181957 Increased amorphous stability of poorly water soluble drugs by nanosizing |
| 07/31/2008 | US20080181956 Improved skin feel through the use silicone elastomers; high percentage of silicone fluid; high percentage of particulate material having a low refractive index; stable and have a silky; non-greasy feel; polymeric thickener, water |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181953 Composition containing a tensioning polymer and hybrid particles, methods of use |
| 07/31/2008 | US20080181952 Perfusive Organ Hemostasis |
| 07/31/2008 | US20080181951 Treatment of humans with colloidal silver composition |
| 07/31/2008 | US20080181949 Nanoemulsion Vaccines |
| 07/31/2008 | US20080181948 Solid pharmaceutical dosage formulations |
| 07/31/2008 | US20080181947 Controlled release dosage form of tacrolimus |
| 07/31/2008 | US20080181946 Controlled Release Delivery System For Metformin |
| 07/31/2008 | US20080181945 Method for the treatment of acne |
| 07/31/2008 | US20080181944 semipermeable walled container that houses a capsule comprising a drug formulation, a piston, and an osmotic composition; releases the drug through a passageway at controlled rate over a sustained release period of time; progestin and estrogen |
| 07/31/2008 | US20080181943 short-acting agent selected from: GABA-A receptors modulators, benzodiazepine, phenothiazine, melatonin derivative and melatonin agonist; long-acting agent selected from: GABA-A receptors modulators, benzodiazepine, 5HT2A receptor antagonist and calcium ion modulator; sleep disorders |
| 07/31/2008 | US20080181942 inter alia, treating and/or preventing symptoms; Spasticity |
| 07/31/2008 | US20080181941 Inert pharmaceutically acceptable substrates containing an analgesic with diameter of .1 mm-3 mm, effective blood levels for at least 24 hours; Opioids; solid dosage form; sustained release |
| 07/31/2008 | US20080181940 Method For Accelerating Expression of CPT-1 |
| 07/31/2008 | US20080181939 hydrolysis triggered, controlled release polymersome nano-system for delivering a cytotoxic, anticancer therapeutic active agent to cell; stable, synthetic, self-assembling, controlled release, polyethylene oxide-based vesicles; semi-permeable, thin-walled, amphiphilic, high molecular weight |
| 07/31/2008 | US20080181938 containing lipids and an alcohol; gene therapy; further includes a biocide, benzethonium chloride; permeation enhancer |
| 07/31/2008 | US20080181937 Vitamin C, Vitamin E, DHA and Curcumin; treating an individual who is at increased risk of developing Alzheimer's disease because of family history |
| 07/31/2008 | US20080181935 Base-treated, detergent-treated telopeptide collagen and a plurality of stem cells; kit for augmenting, bulking or replacing tissue of a mammal |
| 07/31/2008 | US20080181934 medication are delivered in pleasant tasting delivery vehicles, including gelatins and candies; kits; to mask noxious taste |
| 07/31/2008 | US20080181933 for reducing nicotine addiction; including a water insoluble base portion; a water soluble portion |
| 07/31/2008 | US20080181932 inner core comprising an inert material, the outer layer comprising a plurality of pharmaceutically active agents embedded in a matrix, the matrix being substantially erodable when contacted with an aqueous medium |
| 07/31/2008 | US20080181929 biodegradable polymer and a therapeutic agent for the treatment of retinal tissue; active substance is at least one member selected from the group consisting of dexamethasone and fluocinolone |
| 07/31/2008 | US20080181919 Shiunko nanomicell for skin treatment and preparation method for the same |
| 07/31/2008 | US20080181905 Nanoemulsion Vaccines |
| 07/31/2008 | US20080181867 preparing a pre-concentrate by emulsifying an oil phase castor oil with water and a water soluble pharmaceutically active substance cyclosporine A, then dilute to desired concentration; eye drops for eye disorders; less time and low energy consuming, no negative impact on the chemical stability |
| 07/31/2008 | US20080181854 antiinflammatory ascomycin derivative pimecrolimus in the form of a foam; inflammatory and hyperproliferative skin diseases and of cutaneous manifestations of immunologically-mediated diseases |
| 07/31/2008 | US20080181826 uniform heating and cooling of the containers, preventing stress cracks; gentle; use of radiant heat-generating heating units that act on the container bottoms in concert with the hot air from the ventilating fan units |
| 07/31/2008 | DE4400295B4 Verfahren zum Herstellen eines sphärischen Granulums A method for producing a spherical granule |
| 07/31/2008 | DE102007005191A1 Molecular drug transport system for producing medicine for specific transmission of incorporated active substance molecules into living cells in vitro and in vivo, has additional binding forces |
| 07/31/2008 | DE102007004663A1 Wound healing agent has substantial components water and silicon dioxide with particle size 50-200 nm, and amount of silicon dioxide is 1-5 percent by weight |
| 07/31/2008 | CA2676105A1 The tetracyclic anthraquinones possessing anti-cancer effect |
| 07/31/2008 | CA2675972A1 Polypeptide films and methods |
| 07/31/2008 | CA2675788A1 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 07/31/2008 | CA2675766A1 Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability |
| 07/31/2008 | CA2675538A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | CA2619193A1 Polyphenol-based composition, and methods and systems for its preparation |
| 07/30/2008 | EP1950232A1 Process for the preparation of graft copolymers by Reversible Addition Fragmentation Chain Transfer (RAFT) and Ring Opening Polymerisation (ROP) |
| 07/30/2008 | EP1950227A1 HYDROXYPROPYL-SULFOBUTYL-ß-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF |
| 07/30/2008 | EP1950205A1 Method for stabilization of isoxazole compound |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1949909A1 Use of Botulinum Toxin Therapy for Treatment of Urge Type Dysfunction |
| 07/30/2008 | EP1949900A2 Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof |
| 07/30/2008 | EP1949895A1 Iontophoresis preparation |
| 07/30/2008 | EP1949892A1 Aerosol for inhalation comprising a tiotropium salt |
| 07/30/2008 | EP1949891A1 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
| 07/30/2008 | EP1949890A2 Implantable gel compositions and method of manufacture |
| 07/30/2008 | EP1949888A1 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |